To ask the Secretary of State for Science, Innovation and Technology, pursuant to the Answer of 14 February to Question 29747 on AstraZeneca, if he will place a copy of the requested letter in the House of Commons Library.
Due to commercial confidentiality considerations, we are unable to place the requested letter in the House of Commons Library. As with any application for Government grant funding of this nature, all cases undergo rigorous due diligence, which assesses wh...
AstraZeneca